Cohort study of the neonatal outcome of twin pregnancies that were treated with prophylactic or rescue antenatal corticosteroids

Am J Obstet Gynecol. 2002 Aug;187(2):483-8. doi: 10.1067/mob.2002.123891.

Abstract

Objective: The purpose of this study was to compare the neonatal outcome of 2 approaches to antenatal corticosteroid therapy for threatened preterm delivery in twins: a prophylactic approach in which corticosteroids were administered every 2 weeks from 24 to 32 weeks of gestation and a rescue approach in which corticosteroids were given to women at immediate risk of preterm delivery.

Study design: A retrospective cohort study of 1038 twin babies delivered between 1990 and 1996 in a University Teaching Hospital. One hundred thirty-six babies were exposed to prophylactic therapy, and 902 babies were treated expectantly with rescue therapy.

Results: Prophylactic corticosteroids were not associated with a significant reduction in respiratory distress syndrome (adjusted odds ratio, 0.7; 95% CI, 0.2-2.0). Unnecessary therapy was more likely with a prophylactic policy (relative risk, 7.5; 95% CI, 5.3-10.7) and was associated with a reduction in mean birth weight in term babies of 129 g (95% CI, -218 to -33; P =.008).

Conclusion: Prophylactic corticosteroids have no proven beneficial effect on the risk of respiratory distress syndrome in preterm twin babies. Such a policy exposes a large number of babies to unnecessary treatment that adversely affects growth.

Publication types

  • Comparative Study

MeSH terms

  • Birth Weight
  • Cohort Studies
  • Dexamethasone / administration & dosage*
  • Female
  • Glucocorticoids / administration & dosage*
  • Humans
  • Infant, Newborn
  • Male
  • Obstetric Labor, Premature / prevention & control*
  • Pregnancy
  • Pregnancy Outcome
  • Pregnancy, Multiple / physiology*
  • Respiratory Distress Syndrome, Newborn / prevention & control*
  • Retrospective Studies
  • Treatment Outcome
  • Twins*
  • Unnecessary Procedures

Substances

  • Glucocorticoids
  • Dexamethasone